These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21106381)
1. Automation of labelling of Lipiodol with high-activity generator-produced 188Re. Lepareur N; Ardisson V; Noiret N; Boucher E; Raoul JL; Clément B; Garin E Appl Radiat Isot; 2011 Feb; 69(2):426-30. PubMed ID: 21106381 [TBL] [Abstract][Full Text] [Related]
2. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin. Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262 [TBL] [Abstract][Full Text] [Related]
3. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma. Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868 [TBL] [Abstract][Full Text] [Related]
4. Preparation of Rhenium-188-Lipiodol Using Freeze-Dried Kits for Transarterial Radioembolization: An Overview and Experience in a Hospital Radiopharmacy. Radhakrishnan ER; Chirayil V; Pandiyan A; Subramanian S; Mallia MB; Kamaleshwaran KK; Shinto A Cancer Biother Radiopharm; 2022 Feb; 37(1):63-70. PubMed ID: 34101501 [No Abstract] [Full Text] [Related]
5. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496 [TBL] [Abstract][Full Text] [Related]
6. Automated radiosynthesis of the thiol-reactive labeling agent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM). Kniess T; Kuchar M; Pietzsch J Appl Radiat Isot; 2011 Sep; 69(9):1226-30. PubMed ID: 21507666 [TBL] [Abstract][Full Text] [Related]
7. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs. Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613 [TBL] [Abstract][Full Text] [Related]
8. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours. Lambert B; Bacher K; Defreyne L Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309 [TBL] [Abstract][Full Text] [Related]
9. Fully automated synthesis and coupling of [(18) F]FBEM to glutathione using the iPHASE FlexLab module. Ackermann U; Plougastel L; Wichmann C; Goh YW; Yeoh SD; Poniger SS; Tochon-Danguy HJ; Scott AM J Labelled Comp Radiopharm; 2014 Feb; 57(2):115-20. PubMed ID: 24395455 [TBL] [Abstract][Full Text] [Related]
10. Development of Semiautomated Module for Preparation of Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645 [TBL] [Abstract][Full Text] [Related]
11. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection. Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model. Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647 [TBL] [Abstract][Full Text] [Related]
13. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig. Garin E; Noiret N; Malbert CH; Lepareur N; Roucoux A; Dazord L; Caulet-Maugendre S; Turlin B; Moisan A; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449 [TBL] [Abstract][Full Text] [Related]
14. Novel and efficient preparation of precursor [188Re(OH2)3(CO)3]+ for the labeling of biomolecules. Park SH; Seifert S; Pietzsch HJ Bioconjug Chem; 2006; 17(1):223-5. PubMed ID: 16417272 [TBL] [Abstract][Full Text] [Related]
15. Automated radiolabelling of monoclonal antibodies with the Modular Lab system. Ellison D; Kaufman J; Mather SJ Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma. Huang PW; Tsai SC; Luo TY; Kao CH; Lin WY Ann Nucl Med; 2013 Jul; 27(6):532-7. PubMed ID: 23479326 [TBL] [Abstract][Full Text] [Related]
17. Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment. Lepareur N; Laffont S; Ardisson V; Noiret N; Garin E Nucl Med Commun; 2012 Feb; 33(2):205-8. PubMed ID: 22124362 [TBL] [Abstract][Full Text] [Related]
18. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies. Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195 [TBL] [Abstract][Full Text] [Related]
19. Rhenium-188 labeled hydroxyapatite and rhenium-188 sulfur colloid. In vitro comparison of two agents for radiation synovectomy. Grillenberger KG; Glatz S; Reske SN Nuklearmedizin; 1997 Mar; 36(2):71-5. PubMed ID: 9090648 [TBL] [Abstract][Full Text] [Related]
20. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer. Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]